Infective endocarditis in intravenous drug abusers: clinical challenges emerging from a single-centre experience

Valentina Scheggi, Stefano Del Pace, Nicole Ceschia, Francesco Vanni, Irene Merilli, Edoardo Sottili, Leonardo Salcuni, Nicola Zoppetti, Bruno Alterini, Alfredo Cerillo, Niccolò Marchionni, Pier Luigi Stefàno, Valentina Scheggi, Stefano Del Pace, Nicole Ceschia, Francesco Vanni, Irene Merilli, Edoardo Sottili, Leonardo Salcuni, Nicola Zoppetti, Bruno Alterini, Alfredo Cerillo, Niccolò Marchionni, Pier Luigi Stefàno

Abstract

Background: Intravenous drug abuse (IDA) is a known risk factor for infective endocarditis (IE) and is associated with frequent relapses, but its prognostic impact is still debated. The potential futility of surgery in this population is a further issue under discussion. We aimed to describe the clinical characteristics, the therapeutic strategy, and the prognosis associated with IDA in IE.

Methods: We retrospectively analysed 440 patients admitted to a single surgical centre for definite active IE from January 2012 to December 2020.

Results: Patients reporting IDA (N = 54; 12.2%) were significantly younger (p < 0.001) and presented fewer comorbidities (p < 0.001). IDA was associated with a higher proportion of relapses (27.8 vs. 3.3%, p < 0.001) and, at multivariable analysis, was an independent predictor of long-term mortality (HR 2.3, 95%CI 1.1-4.7, p = 0.015). We did not register multiple relapses in non-IDA patients. Among IDA patients, we observed 1 relapse after discharge in 9 patients, 2 relapses in 5 patients and 3 relapses in 1 patient. In IDA patients, neither clinical and laboratory variables nor the occurrence of even multiple relapses emerged as indicators of an adverse risk-benefit ratio of surgery in patients with surgical indication.

Conclusions: IE secondary to IDA affects younger patients than those with IE not associated with IDA. Probably due to this difference, IE secondary to IDA is not associated with significantly higher mortality, whereas the negative, long-term prognostic impact of IDA emerges in multivariate analysis. Considering the good prognosis of patients with uncomplicated IE treated medically, surgery should be reserved to patients with a strict- guidelines-based indication. However, since there are no clear predictors of an unfavourable risk-benefit ratio of surgery in patients with surgical indication, all patients with a complicated IE should be operated, irrespective of a history of IDA.

Keywords: Cardiac surgery; Infective endocarditis; Intravenous drug abuse; Prognosis.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Kaplan–Meier survival analysis of 440 patients with infective endocarditis associated and non-associated with intravenous drug abuse (IDA)

References

    1. Rudasill SE, Sanaiha Y, Mardock AL, Khoury H, Xing H, Antonios JW, McKinnell JA, et al. Clinical outcomes of infective endocarditis in injection drug users. J Am Coll Cardiol. 2019;73(5):559–570. doi: 10.1016/j.jacc.2018.10.082.
    1. Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis. 2000;30(2):374–379. doi: 10.1086/313664.
    1. Rohn V, Laca B, Horn M, Vlk L, Antonova P, Mosna F. Surgery in drug use-associated infective endocarditis: long-term survival is negatively affected by recurrence. Interact Cardiovasc Thorac Surg. 2020;30(4):528–534. doi: 10.1093/icvts/ivz302.
    1. Shrestha NK, Jue J, Hussain ST, Jerry JM, Pettersson GB, Menon V, et al. Injection drug use and outcomes after surgical intervention for infective endocarditis. Ann Thorac Surg. 2015;100(3):875–882. doi: 10.1016/j.athoracsur.2015.03.019.
    1. Rodger L, Glockler-Lauf SD, Shojaei E, Sherazi A, Hallam B, Koivu S, et al. Clinical characteristics and factors associated with mortality in first-episode infective endocarditis among persons who inject drugs. JAMA Netw Open. 2018;1(7):e185220. doi: 10.1001/jamanetworkopen.2018.5220.
    1. Nguemeni Tiako MJ, Mori M, Bin Mahmood SU, Shioda K, Mangi A, Yun J, et al. Recidivism is the leading cause of death among intravenous drug users who underwent cardiac surgery for infective endocarditis. Semin Thorac Cardiovasc Surg. 2019;31(1):40–45. doi: 10.1053/j.semtcvs.2018.07.016.
    1. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, ESC Scientific Document Group et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM) Eur Heart J. 2015;36(44):3075–3128. doi: 10.1093/eurheartj/ehv319.
    1. Scheggi V, Alterini B, Olivotto I, Del Pace S, Zoppetti N, Tomberli B, et al. Embolic risk stratification and prognostic impact of early surgery in left-sided infective endocarditis. Eur J Intern Med. 2020;78:82–87. doi: 10.1016/j.ejim.2020.04.017.
    1. Del Pace S, Scheggi V, Virgili G, Caciolli S, Olivotto I, Zoppetti N, et al. Endocarditis with spondylodiscitis: clinical characteristics and prognosis. BMC Cardiovasc Disord. 2021;21(1):186. doi: 10.1186/s12872-021-01991-x.
    1. Scheggi V, Merilli I, Marcucci R, Del Pace S, Olivotto I, Zoppetti N, et al. Predictors of mortality and adverse events in patients with infective endocarditis: a retrospective real world study in a surgical centre. BMC Cardiovasc Disord. 2021;21(1):28. doi: 10.1186/s12872-021-01853-6.
    1. Habib G, Lancellotti P, Erba PA, Sadeghpour A, Meshaal M, Sambola A, EURO-ENDO Investigators et al. The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. Eur Heart J Qual Care Clin Outcomes. 2019;5(3):202–207. doi: 10.1093/ehjqcco/qcz018.
    1. Habib G, Gouriet F, Casalta JP. Infective endocarditis in injection drug users: a recurrent disease. J Am Coll Cardiol. 2019;73(5):571–572. doi: 10.1016/j.jacc.2018.10.081.
    1. Weymann A, Borst T, Popov AF, Sabashnikov A, Bowles C, Schmack B, et al. Surgical treatment of infective endocarditis in active intravenous drug users: a justified procedure? J Cardiothorac Surg. 2014;24(9):58. doi: 10.1186/1749-8090-9-58.
    1. Serota DP, Wilson JD, Merlin JS. Injection drug use-associated infective endocarditis. JAMA. 2018;320(18):1939. doi: 10.1001/jama.2018.14071.
    1. Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016;375(4):357–368. doi: 10.1056/NEJMra1604339.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe